Bevacizumab and Irinotecan to Treat Brain Tumors
Clinical trial NCT00393094 · TERMINATED
Trial details
- NCT number
- NCT00393094
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2010-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.